+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Transcatheter Mitral Valve"

Transcatheter Heart Valves - Global Strategic Business Report - Product Thumbnail Image

Transcatheter Heart Valves - Global Strategic Business Report

  • Report
  • January 2026
  • 247 Pages
  • Global
From
From
Structural Heart Devices - Global Strategic Business Report - Product Thumbnail Image

Structural Heart Devices - Global Strategic Business Report

  • Report
  • January 2026
  • 194 Pages
  • Global
From
Interventional Cardiology Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Interventional Cardiology Market - Forecasts from 2025 to 2030

  • Report
  • November 2025
  • 148 Pages
  • Global
From
From
From
Cardiovascular Devices Market Report and Forecast 2025-2034 - Product Thumbnail Image

Cardiovascular Devices Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
From
From
From
From
From
From
From
North America Heart Valve Devices Market Report and Forecast 2025-2034 - Product Thumbnail Image

North America Heart Valve Devices Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 300 Pages
  • North America
From
Loading Indicator

The Transcatheter Mitral Valve (TMV) is a type of cardiovascular device used to treat mitral valve regurgitation, a condition in which the mitral valve does not close properly, allowing blood to flow backward into the left atrium. TMV is a minimally invasive procedure that involves the insertion of a prosthetic valve into the heart through a catheter. This procedure is an alternative to open-heart surgery, which is more invasive and carries a higher risk of complications. TMV is a rapidly growing market, with a number of companies developing and marketing products. These companies are focused on improving the safety and efficacy of TMV procedures, as well as expanding the range of patients who can benefit from the procedure. Companies in the TMV market include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, and Neovasc. Show Less Read more